Sökresultat

Filtyp

Din sökning på "credit fc 26 pas cher Visitez le site Buyfc26coins.com Pas de déception avec mes achats de FC 26 coins.kxEU" gav 49272 sökträffar

Brevmall

Brevmall KRM C12 Litteraturlista Humaniora och teo log i Centrum fö r teo log i och re l ig ionsvetenskap Litteraturlista för KRMC12 Kyrko- och missionsstudier: Fördjupningskurs, 15 hp, HT 2019 fastställd av studierektor 2019-05-24 Delkurs 1. Tradition och förändring - Den tidiga kyrkan och nutidens utmaningar, 10 hp Obligatorisk del: Teori om tradition och traditionsförändring Allen, Graham (2011

https://www.ctr.lu.se/media/utbildning/dokument/kurser/KRMC12/20192/KRM_C12_Litteratur.pdf - 2026-05-04

Minor Field Studies

Minor Field Studies (MFS) is a grant programme funded by Sida, offering students the opportunity to conduct field studies in countries where Sweden has active strategies for development cooperation. Shortcuts to page content:About the grantHow to applyAfter you have sent in your applicationIf you are awarded a grant Applications are open 5–25 April Contact information Maria NilssonDivision of Glob

https://www.lunduniversity.lu.se/current-students/international-opportunities/grants-and-scholarships-studies-and-traineeships-abroad/minor-field-studies - 2026-05-05

2025

Det korsvisa skyddet - Om EU-domstolens dom i mål C-365/24, Purefun Group10 december 2025 17:30 till 19:30Pufendorfsalen, Juridicum i Lund & Online (Zoom)Den 10 juli 2025 meddelade EU-domstolen dom i mål C-365/24, Purefun Group. Målet har sin upprinnelse i en intrångstvist i Sverige som lett till att PMÖD ställt ett antal frågor till EU-domstolen, däribland frågan om det är förenligt med

https://www.aclu.lu.se/evenemang/genomforda-evenemang/2025 - 2026-05-05

Max Koch

FD och habilitation i sociologi från Freie Universität Berlin | Professor Kontaktinformation E-post: max [dot] koch [at] soch [dot] lu [dot] se Telefon: +46 46 222 12 68Organisation Socialhögskolan Rumsnummer: 328 Hämtställe: 28 WebbplatsMax Kochs profil i Lunds universitets forskningsportalAndra roller Professor Socialpolitik och hållbarhet Profilområdesmedlem LU profilområde: Naturbaserade framt

https://www.soch.lu.se/max-koch - 2026-05-06

2016-07090 programbidrag lagesrapport userage 20190830 x

2019-08-30 Scientific report Information about the grant Registration number: 2016-07090 Grant recipient: Iwarsson, Susanne Administrating organisation: Lunds univers i tet Project site: Hälsovetenskaper 314500 Project title (english): UserAge: Understanding User Participation in Research on Ageing and Health Grant period: 2017-01-01 - 2019-12-31 Total granted amount: 9,000,000 Grant expiry date:

https://www.case.lu.se/sites/case.lu.se/files/2016-07090_programbidrag_lagesrapport_userage_20190830_x.pdf - 2026-05-07

The mitochondrial outer membrane AAA ATPase AtOM66 affects cell death and pathogen resistance in Arabidopsis thaliana

One of the most stress-responsive genes encoding a mitochondrial protein in Arabidopsis (At3g50930) has been annotated as AtBCS1 (cytochrome bc1 synthase 1), but was previously functionally uncharacterised. Here, we show that the protein encoded by At3g50930 is present as a homo-multimeric protein complex on the outer mitochondrial membrane and lacks the BCS1 domain present in yeast and mammalian

A membrane-bound NAC transcription factor, ANAC017, mediates mitochondrial retrograde signaling in Arabidopsis

Plants require daily coordinated regulation of energy metabolism for optimal growth and survival and therefore need to integrate cellular responses with both mitochondrial and plastid retrograde signaling. Using a forward genetic screen to characterize regulators of alternative oxidase1a (rao) mutants, we identified RAO2/Arabidopsis NAC domain-containing protein17 (ANAC017) as a direct positive re

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer

Tamoxifen therapy resistance constitutes a major cause of death in patients with recurrent estrogen receptor (ER) positive breast cancer. Through high resolution mass spectrometry (MS), we previously generated a 4-protein predictive signature for tamoxifen therapy outcome in recurrent breast cancer. ANXA1 and CALD1, which were not included in the classifier, were however the most differentially ex

International registry of otolaryngologist–head and neck surgeons with COVID-19

Background: It has become clear that healthcare workers are at high risk, and otolaryngology has been theorized to be among the highest risk specialties for coronavirus disease 2019 (COVID-19). The purpose of this study was to detail the international impact of COVID-19 among otolaryngologists, and to identify instructional cases. Methods: Country representatives of the Young Otolaryngologists–Int

Estimating Global Burden of Disease due to congenital anomaly : An analysis of European data

Objective To validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by comparing infant mortality data collected by EUROCAT registries with the WHO Mortality Database, and by assessing the significance of stillbirths and terminations of pregnancy for fetal anomaly (TOPFA) in the interpretation of infant mortality statistics. Design, setting and outcome measur

Fission in the landscape of heaviest elements: Some recent examples

The fission process still remains a main factor that determines the stability of the atomic nucleus of heaviest elements. Fission half-lives vary over a wide range, 10^−19 to 10^24 s. Present experimental techniques for the synthesis of the superheavy elements that usually measure α-decay chains are sensitive only in a limited range of half-lives, often 10^5 to 10^3 s. In the past years, measureme

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4) : A multicentre, open-label, randomised, phase 3 trial

Background: The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant 5-fluorouracil/folinic acid in patients with resected pancreatic cancer. Other clinical trials have shown better survival and tumour response with gemcitabine and capecitabine than with gemcitabine alone in advanced or metastatic pancreatic cancer. We

The Gaia-ESO Survey: Detailed abundances in the metal-poor globular cluster NGC 4372

We present the abundance analysis for a sample of 7 red giant branch stars in the metal-poor globular cluster NGC 4372 based on UVES spectra acquired as part of the Gaia-ESO Survey. This is the first extensive study of this cluster from high-resolution spectroscopy. We derive abundances of O, Na, Mg, Al, Si, Ca, Sc, Ti, Fe, Cr, Ni, Y, Ba, and La. We find a metallicity of [Fe/H] = -2.19 +/- 0.03 an

Prolate shape of Ba-140 from a first combined Doppler-shift and Coulomb-excitation measurement at the REX-ISOLDE facility

Background: Quadrupole moments of excited nuclear states are important observables for geometrically interpreting nuclear structure in terms of deformed shapes, although data are scarce and sometimes ambiguous, in particular, in neutron-rich nuclides. Purpose: A measurement was performed for determining the spectroscopic quadrupole moment of the 2(1)(+) state of Ba-140 in order to clarify the char

PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

Next-generation sequencing experiments have shown that microRNAs (miRNAs) are expressed in many different isoforms (isomiRs), whose biological relevance is often unclear. We found that mature miR-21, the most widely researched miRNA because of its importance in human disease, is produced in two prevalent isomiR forms that differ by 1 nt at their 3' end, and moreover that the 3' end of miR-21 is po

Prostate-Cancer Mortality at 11 Years of Follow-up

Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on prostate-cancer mortality have shown conflicting results. We updated prostate-cancer mortality in the European Randomized Study of Screening for Prostate Cancer with 2 additional years of follow-up. Methods The study involved 182,160 men between the ages of 50 and 74 years at entry, with a predefined core

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial

BackgroundIbrutinib, a Bruton tyrosine kinase inhibitor, prolongs progression-free survival when added to immunochemotherapy as first line treatment. The ENRICH trial compared the chemotherapy-free combination of ibrutinib and the anti-CD20 antibody rituximab (ibrutinib–rituximab) with standard immunochemotherapy (R-CHOP [rituximab–cyclophosphamide, doxorubicin, vincristine, and prednisolone] or b